Department of Brain Health News
The department of brain health is dedicated to advancing research, education, and clinical care to benefit brain health and the care and treatment of people with brain disorders across the lifespan. The faculty specializes in several areas that range from basic to clinical research in neurodegenerative disease and stroke.
Current Brain Health News
The top news stories starring university students and staff.
Data provided by UNLV researchers helped secure FDA approval for a new blood test to detect Alzheimer’s disease.
The top headlines featuring UNLV’s staff and students.
Report led by noted Alzheimer's researcher Dr. Jeffrey Cummings assesses status, trends associated with 182 active clinical trials worldwide.
UNLV research team says high blood sugar levels appear to weaken function in key part of brain, mimicking Alzheimer’s.
The 'Brain Health Frontiers: Tackling Alzheimer's Together' panel discussion highlighted the revolutionary research the Department of Brain Health is conducting to fight Alzheimer’s disease.
Brain Health In The News
Details from two large trials of Novo Nordisk's NOVOb.CO GLP-1 drug semaglutide showed it provided no cognitive benefit for people with early Alzheimer's disease, researchers said at a medical meeting on Wednesday, dashing remaining hopes that the widely used medication could help such patients.
When Herriot Tabuteau launched his drug development company, Axsome Therapeutics, in 2012, he decided to do things differently by focusing on treatments for brain disorders that are particularly challenging to develop. Now, he’s sitting on a $6 billion empire, according to Forbes.
Detect Alzheimer's disease early with a groundbreaking blood test that could change the game for millions of people worldwide! This revolutionary diagnostic tool can identify the disease years before symptoms appear, giving patients and their families a head start on treatment and care. The FDA just cleared the first blood test for identifying patients with amyloid pathology associated with Alzheimer’s disease — and part of the research behind its approval was conducted by leading experts at the UNLV Department of Brain Health, with chair and renowned brain health researcher, Jefferson Kinney, PhD, our guest for today’s Show. In this video, we'll dive into the science behind this innovative test, how it works, and what it means for the future of Alzheimer's research and treatment. If you or a loved one is at risk for Alzheimer's, you won't want to miss this!
In the United States, 12% of adults have taken a glucagon-like peptide 1 (GLP-1) antagonist. The drugs aren’t just popular for weight loss; 62% of adults taking semaglutide or other GLP-1 drugs take them for chronic conditions, such as diabetes and heart disease — and dementia could be added to that list.
The gunman who killed four people in Midtown Manhattan claims in a suicide note that he wanted his brain to be studied for CTE, the degenerative brain disease associated with repeated hits to the head. Chronic Traumatic Encephalopathy, also known as CTE, has been found in former National Football League and National Hockey League players, boxers, and members of the military.
Shane Tamura, the Las Vegas man responsible for a New York City shooting that left 4 dead, blamed football and the NFL for his perceived struggle with the neurodegenerative disease chronic traumatic encephalopathy (CTE).
